Key result
Alzheimer's disease was associated with elevated CSF ACE1 activity compared to controls, indicating renin-angiotensin system dysfunction.
Why the study?
It was unknown whether cerebrospinal fluid markers of the renin-angiotensin system are altered in Alzheimer's disease in relation to established pathology and capillary dysfunction markers.
Are cerebrospinal fluid markers of the renin-angiotensin system altered in Alzheimer's disease compared to controls?
Cross-Sectional (n=80)
Are cerebrospinal fluid markers of the renin-angiotensin system altered in Alzheimer's disease compared to controls?
Answers are grounded in this paper and cite their sources.
This study suggests that renin-angiotensin system dysfunction, specifically elevated ACE1 activity, is present in Alzheimer's disease and correlates with markers of capillary damage.
Observations in autopsied brain tissue indicate that overactivation of the classical renin-angiotensin system (cRAS) and underactivity within regulatory RAS pathways (rRAS) are associated with pathology in Alzheimer's disease (AD). The primary aim of this study was to investigate whether cerebrospinal fluid (CSF) markers of RAS are altered in AD in relation to established CSF markers of disease pathology (lower Aβ42 and elevated tau) and CSF markers of capillary dysfunction. We studied 40 controls and 40 AD cases grouped according to a biomarker profile (i.e., AD cases t-tau>400 pg/mL, pTau >60 pg/mL, and Aβ42 <550 pg/mL). Angiotensin-II converting enyme-1 (ACE1) and ACE2 enzyme activity was measured using fluorogenic peptide substrates; sPDGFRβ and albumin level by sandwich ELISA; and angiotensin-I (Ang-I), Ang-II, and Ang-(1-7) by direct ELISA. CSF Aβ42, total, and phosphorylated tau levels were previously measured by INNOTEST sandwich ELISA. CSF ACE1 activity was significantly elevated in AD (p = 0.008) and positively correlated with ACE2 in AD (r = 0.420, p = 0.007). CSF ACE1 weakly correlated with t-tau (r = 0.294, p = 0.066) and p-tau (r = 0.329, p = 0.038) but not with Aβ42 in the controls but not in AD. ACE1 correlated positively with sPDGFRβ (r = 0.426, p = 0.007), a marker of pericyte injury, and ACE2 correlated positively with albumin (r = 0.422, p = 0.008), a marker of blood-brain barrier integrity. CSF Ang-I, Ang-II, and Ang-(1-7) levels were unchanged in AD. This cross-sectional CSF study indicates RAS dysfunction in relation to capillary damage in AD.
No takes yet. Share an insight, caveat, or question.
Kehoe et al. (2019) conducted a cross-sectional in Alzheimer's disease (n=80). Alzheimer's disease vs. Controls was evaluated on CSF ACE1 activity (p=0.008). Alzheimer's disease was associated with elevated CSF ACE1 activity compared to controls, indicating renin-angiotensin system dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: